Rates of both periodontal disease and cardiovascular disease are elevated in individuals with rheumatoid arthritis. New research published in Arthritis & Rheumatology suggests that immune responses to certain bacteria that ...
Nov 18, 2020
0
4
A collaborative team of scientists has pinpointed two new potential therapeutic targets for rheumatoid arthritis—a painful inflammatory disease that affects an estimated 350 million people worldwide.
Nov 12, 2020
0
41
Since doctors began treating cancer patients with immunotherapy drugs called checkpoint inhibitors nearly a decade ago, they have observed that a subset of these patients experience a side effect that clinically looks like ...
Nov 9, 2020
0
2
The incidence of dementia in patients with rheumatoid arthritis is lower in patients receiving biologic or targeted synthetic disease modifying antirheumatic drugs (DMARDs) than in patients who receive conventional synthetic ...
Nov 7, 2020
0
7
New research at ACR Convergence, the American College of Rheumatology's annual meeting, reveals that people of color with rheumatic disease have worse health outcomes from COVID-19 infection, are more likely to be hospitalized ...
Nov 6, 2020
0
0
A new study shows that the COVID-19 infection incidence has been low in people with rheumatic diseases, and most of those infected experience a mild course of illness. Additionally, fatalities have been low among rheumatic ...
Nov 6, 2020
0
11
A new study reveals that Black patients with rheumatoid arthritis (RA) were less likely to be prescribed a biologic treatment and more likely to use glucocorticoids, which carry a risk of serious long-term side effects. This ...
Nov 6, 2020
0
2
New research presented at ACR Convergence, the American College of Rheumatology's annual meeting, discovers that use of hydroxychloroquine, a generic drug, does not cause any significant differences in QTc length or prolonged ...
Nov 6, 2020
0
3
Musculoskeletal disorders—which affect muscles, tendons, ligaments, bones, and joints—can severely affect individuals' physical and mental health, and they're especially prevalent among aging adults. Although many researchers ...
Nov 5, 2020
0
4
A new study led by researchers at Queen Mary University of London provides potential novel biomarkers for predicting patient responsiveness to disease modifying anti-rheumatic drugs (DMARDs).
Oct 27, 2020
0
74
